Alliance Pharma Appoints Patrick Bennett as Chief Executive Officer

Alliance Pharma, a leader in small and large molecule bioanalytical services in the pharmaceutical and biopharmaceutical industry, announces that Patrick Bennett has been named Chief Executive Officer. Bennett has more than 30 years of experience in the industry, including 25 years in leadership roles at various bioanalytical contract research organizations, most recently as Vice President, Strategy and Development at PPD Laboratories. Prior to PPD, Bennett served as the Director of Global Strategic Marketing at ThermoFisher Scientific, and at various executive level positions with Tandem Labs.

Throughout his career, Patrick has developed broad bioanalytical expertise and established a strong reputation as a leader and innovator in laboratory operations. In his most recent roles, he established biomarker, cell and gene therapy operations, and a state-of-the-art bioanalytical lab in China.

"Alliance will execute an aggressive global growth strategy, and there is no one more timely, skilled, or better suited to lead Alliance than Pat. His operational expertise, global experience, long-term relationship-driven nature, and exceptional communication skills are a perfect fit for Alliance," explained Dave Patteson, Chairman of the Board at Alliance and a Partner at Ampersand, Alliance's principal owner.